2284P Pre-clinical assessment of the therapeutic potential of a CD80-Fc-armed oncolytic virus (VSV-GP-CD80Fc)A. Ackermann, Jörg F. Rippmann, Patrik Erlmann et al.|Annals of Oncology|2023Cited by 0
Abstract 6658: TcE armed oncolytic virus VSV-GP combines oncolysis and T-cell retargeting for improved efficacyAparna Ponnurangam, Nolden Tobias, Melissa Mayr et al.|Cancer Research|2024Cited by 0